Researchers from the Microtubule Organization lab, headed by Jens Lüders at IRB Barcelona, and the Macromolecular Complexes in DNA Damage Response Group, led by Oscar Llorca at the Spanish National C...
Read more
El Institut de Recerca Sant Joan de Déu y el Institut de Recerca Biomèdica firman un acuerdo de colaboración para promover acciones conjuntan con el grupo de jóvenes KIDS Barcelona y Crazy About B...
Read more
Scientist Cristina Mayor-Ruiz joins the Institute for Research in Biomedicine (IRB Barcelona) to lead the new Targeted Protein Degradation and Drug Discovery Lab. Along with the addition of this group...
Read more
Researchers from IRB Barcelona, the University of Barcelona (UB) and the Sant Joan de Déu Research Institute – Hospital Sant Joan de Déu (SJD) have set up Gate2Brain, a company based on a novel te...
Read more
Proyectos en salud impulsados por el IRB Barcelona, el CRG, el IBEC y la UAB obtienen las prestigiosas becas del Consejo Europeo de Investigación
Read more
In a study published in Cell Reports,the scientists inhibited the capacity of RAS to block cell death, thus eliminating malignant tumours without affecting the development of organs. The results of th...
Read more
Nine scientists at IRB Barcelona form part of EMBO, an organisation that comprises more than 1,800 outstanding researchers from Europe and around the world specialised in molecular biology. “This wi...
Read more
Francesc Posas Garriga, an internationally acknowledged researcher in the field of cell biology and full professor of the Universitat Pompeu Fabra (UPF), is to take up the position of director of the ...
Read more
Nostrum BioDiscovery has come about from the combined efforts of IRB Barcelona and the BSC-CNS—two research centres of excellence in Barcelona—with the participation of the University of Barcelona...
Read more
One of her research lines addresses Smad proteins. This line is developed together with Joan Massagué, director of the Institute Sloan Kettering in New York. They study the behaviour of these protein...
Read more
IRB Barcelona group leader in the Oncology Programme talks about metastasis, challenges and Barcelona
Read more
The expected end-result will be the obtaining of an optimal formulation and a route of administration of the compound for its use as a drug in patients. This will allow carrying out the regulatory pre...
Read more
A new technique allows the design of solid materia...
El estudio realizado sobre una muestra significati...
Dámaso Molero: “There are great opportunities in Latin America for ...
A study in 27 European countries led by researchers from King’s Coll...
